Question
An O-type blood mother is carrying an A-type blood child. At 31 weeks of pregnancy, she undergoes a newborn hemolytic test, which results in a score of 128. Is this value indicative of a higher risk for the child to suffer from neonatal hemolytic disease?
Answer
It is recommended that both partners undergo an ABO blood type test to detect the presence of anti-A and anti-B antibodies in the body, known as the IgG antibody titer test. Both can undergo blood tests, with results typically available within a week. If the test results are outside the normal range, intervention measures should be taken. Common intervention treatments include a combination of traditional Chinese and Western medicine to prevent the occurrence of fetal and neonatal hemolytic disease. If no intervention is carried out, as pregnancy progresses, the titer in the mother’s body will gradually increase, and the risk of the fetus developing hemolytic disease will also rise.